Doseloop Beta

Terbinafine

medication Under review

An antifungal medication used to treat fungal infections of the skin and nails.

Research summary

AI-Generated Content: This summary was created by AI and may contain errors. Always verify with peer-reviewed sources.

Clinical evidence supports terbinafine's high efficacy in resolving dermatophyte infections in humans, with response rates often exceeding 80% in short-term treatments for skin infections and superior long-term outcomes for nail infections compared to alternatives like itraconazole. Safety is generally favorable, with mild adverse effects in a minority of patients and excellent tolerability across studies. While primarily studied in patients with fungal infections, bioequivalence trials confirm consistent pharmacokinetics in healthy volunteers.

Reported Benefits

Reported Side Effects

Research (3 studies)

RCT

Efficacy and Safety of Terbinafine 500 mg Once Daily in Patients with Dermatophytosis

Indian Journal of Dermatology • 2017 • n=440

Bhatia A, et al.

RCT

Oral terbinafine (Lamisil) in the short-term treatment of fungal infections of the skin: results of a post-marketing surveillance study.

British Journal of Dermatology • 1999

Faergemann J

RCT

Long-term Effectiveness of Treatment With Terbinafine vs Itraconazole in Onychomycosis

JAMA Dermatology • 1995 • n=151

BrΓ€utigam M, et al.

Community updates

No updates yet for this supplement.

Be the first to share your experience!

At a glance

Users tracking 0
Linked studies 3
Researched benefits 1
Side effects noted 1